KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $713.8 million.

  • Dynavax Technologies' Cash & Current Investments fell 15.21% to $647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year decrease of 11.09%. This contributed to the annual value of $713.8 million for FY2024, which is 3.84% down from last year.
  • Dynavax Technologies' Cash & Current Investments amounted to $713.8 million in FY2024, which was down 3.84% from $742.3 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' Cash & Current Investments registered a high of $742.3 million during FY2023, and its lowest value of $165.0 million during FY2020.
  • Its 3-year average for Cash & Current Investments is $693.5 million, with a median of $713.8 million in 2024.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 230.81% in 2021, then fell by 3.84% in 2024.
  • Over the past 5 years, Dynavax Technologies' Cash & Current Investments (Yearly) stood at $165.0 million in 2020, then skyrocketed by 230.81% to $546.0 million in 2021, then grew by 14.37% to $624.4 million in 2022, then grew by 18.88% to $742.3 million in 2023, then fell by 3.84% to $713.8 million in 2024.